TITLE

Wyeth Enters Depression Fray

PUB. DATE
August 2009
SOURCE
Pharmaceutical Representative;Aug2009, Vol. 39 Issue 8, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the launch of Wyeth's print and television campaign for its antidepressant drug Pristiq in the U.S. Andreas Eggert, vice president and global business manager for Pristiq, explains that the campaign targets patients who ignore treatments and discontinue their medications. The advertisement focuses on how Pristiq affects the serotonin and norepinephrine levels of the brain to help patients feel better.
ACCESSION #
43637415

 

Related Articles

  • For Pristiq promo, Wyeth deploys a wind-up doll. Arnold, Matthew // Medical Marketing & Media;Jul2009, Vol. 44 Issue 7, p8 

    The article offers information on television (TV) and print advertisements created by the company Wyeth for Pristiq, a prescription medication for the treatment of mental depression. The advertisements portray the suffering of patients with mental depression. TV advertisements feature a...

  • COMMENTARIES. Craft, Lynette L. // International Journal of Therapy & Rehabilitation;Oct2008, Vol. 15 Issue 10, p464 

    The author reflects on the effects of clinical depression on mental and physical health. She argues that traditional treatment such as psychotherapy and medication are expensive and can have negative side-effects. She suggests that there should be advances and development in antidepressant...

  • Efectividad de mirtazapina en el tratamiento de la depresión con síntomas somáticos asociados. García Campayo, J. // Actas Espanolas de Psiquiatria;ene2008, Vol. 36 Issue 1, p25 

    Introduction. A assessment of the efficacy of mirtazapine in the treatment of depression with somatic symptoms in a 3-months follow-up study. Material and methods. Design: multicenter, prospective, observational, open-label, and non controlled study. Sample: seven hundred and eleven patients...

  • The Association between Disability and Residual Symptoms in Depressive Patients: A 3-Month Follow-Up. Özyüksel, Banu; Uluğ, Berna // Turkish Journal of Psychiatry;2007, Vol. 18 Issue 4, p1 

    Objective: In this 3-month naturalistic follow-up we aimed to investigate depression treatment outcome and the correlation between improvement of depressive symptoms and level of disability. Method: The study included 104 patients with depression that presented to the Hacettepe Psychiatry...

  • Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder. Hunter, Aimee; Cook, Ian; Tartter, Molly; Sharma, Simi; Disse, Gregory; Leuchter, Andrew // Psychopharmacology;Oct2015, Vol. 232 Issue 20, p3833 

    Rationale: A history of antidepressant treatment may predispose subjects toward placebo nonresponse in randomized controlled trials (RCTs) in major depressive disorder (MDD). Objective: The objective of this study is to examine self-reported prior antidepressant treatment and response in...

  • Depression. Christmas, David // Pulse;Oct2015, p80 

    The article discusses ways to overcome depression and the challenges faced by the patients. The steps for managing resistant depression is mentioned which includes instilling hope within patients, reassessing the diagnosis and developing a psychopharmacological plan. The challenges faced by the...

  • Drug Treatment of Depressive Symptoms in Schizophrenia. Möller, Hans-Jürgen // Clinical Schizophrenia & Related Psychoses;Jan2008, Vol. 1 Issue 4, p328 

    Depressive symptoms during schizophrenic psychosis represent an important part of the overall spectrum of psycho-pathological symptoms, not only in the schizoaffective type but also in the core groups of schizophrenic psychosis diagnosed according to the International Classification of...

  • General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. Baghai, Thomas; Blier, Pierre; Baldwin, David; Bauer, Michael; Goodwin, Guy; Fountoulakis, Kostas; Kasper, Siegfried; Leonard, Brian; Malt, Ulrik; Stein, Dan; Versiani, Marcio; Möller, Hans-Jürgen // European Archives of Psychiatry & Clinical Neuroscience;Nov2011, Vol. 261, p207 

    Current gold standard approaches to the treatment of depression include pharmacotherapeutic and psychotherapeutic interventions with social support. Due to current controversies concerning the efficacy of antidepressants in randomized controlled trials, the generalizability of study findings to...

  • Comparing Gabapentin with Clonazepam for Residual Sleeping Problems following Antidepressant Therapy in Patients with Major Depressive Disorder: A Randomized Clinical Trial. Mowla, Arash; Ahmadzadeh, Laaya; Razeghian Jahromi, Leila; Dastgheib, Seyed // Clinical Drug Investigation;Aug2015, Vol. 35 Issue 8, p513 

    Background and Objective: Residual sleeping disturbances after improvement of depression in major depressed patients are associated with more functional problems, increased relapses and more risk of becoming resistant to treatment. The aim of this study was to compare the efficacy of gabapentin...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics